Head-to-head · WeighScore
Luvo Health vs Omada Health
The verdict
Luvo Health takes it — 61/100 to 55.6/100.
Luvo Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Multi-program telehealth brand from LUVO HEALTH, INC.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Luvo Health | Omada Health |
|---|---|---|
| WeighScore | 61/100 | 55.6/100 |
| Grade | C | C |
| Scorecard rank | #305 | #435 |
| Semaglutide | $249/mo (compounded) | Not disclosed |
| Tirzepatide | $339/mo (compounded) | Not disclosed |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Yes | Injection only |
Graded #305 · C
Strengths
- Full price list published openly, by medication and by commitment length, with no intake required
- Offers both compounded and brand-name Ozempic and Zepbound in one place
- Oral semaglutide tablets available as well as injections
- Full refund if a provider disqualifies you before medication is ordered
- LegitScript certification verified against the issued seal, not just the badge
Where it loses points
- Billed per 4 weeks, not per month, which is 13 charges a year rather than 12
- You are charged for the first period as soon as you complete the intake form, before a clinician has reviewed you
- Refunds stop once medication is ordered, and for new patients with no video visit that is at intake submission
- Cancellation needs 72 hours notice before the billing date or you are charged for another cycle
- Bundle refunds are recalculated at the standard non-bundled rate, so the multi-month discount is clawed back
Graded #435 · C
Strengths
- Added GLP-1 prescribing and medication management in late 2025
- Clinicians trained in obesity care, available in all 50 states
- Behavioral support wrapped before, during and after treatment
- GLP-1 Flex Care adds a cash-pay medication pathway in 2026
- Publicly traded, evidence-based virtual care platform
Where it loses points
- Core program distributed via employers and health plans, limited cash-pay
- GLP-1 prescribing is a recent addition still scaling
- GLP-1 Flex Care only rolling out to employers later in 2026
- No transparent published price for the core member program
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.